APA (7th ed.) Citation

Tanaka, K., Koizumi, H., Tamashiro, T., Itagaki, K., Nakayama, M., Maruko, I., . . . Mori, R. (2022). Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: A Japanese multicenter study. Japanese journal of ophthalmology, 66(4), 379-385. https://doi.org/10.1007/s10384-022-00922-3

Chicago Style (17th ed.) Citation

Tanaka, Koji, et al. "Short-term Results for Brolucizumab in Treatment-naïve Neovascular Age-related Macular Degeneration: A Japanese Multicenter Study." Japanese Journal of Ophthalmology 66, no. 4 (2022): 379-385. https://doi.org/10.1007/s10384-022-00922-3.

MLA (9th ed.) Citation

Tanaka, Koji, et al. "Short-term Results for Brolucizumab in Treatment-naïve Neovascular Age-related Macular Degeneration: A Japanese Multicenter Study." Japanese Journal of Ophthalmology, vol. 66, no. 4, 2022, pp. 379-385, https://doi.org/10.1007/s10384-022-00922-3.